Search - tctmd.com

Displaying 241 - 260 of 373

Sort: Relevancy | Date

News Daily News

Un Nuevo Anti Inflamatorio podría Reducir la Estenosis tras la Implantación de SMD en Pacientes de Alto Riesgo

L.A. McKeown

January 13, 2013

News Daily News

Novel Anti-inflammatory May Reduce Restenosis After BMS in High-Risk Patients

L.A. McKeown

January 13, 2013

News Daily News

TCTMD’s Top 10 Most Popular News Stories for 2012

Jason Kahn

January 02, 2013

News Daily News

ROTAXUS Published: Rotational Atherectomy Does Not Increase DES Efficacy

Yael L. Maxwell

December 27, 2012

News Daily News

APPOSITION II Published: Self-Expanding Stent Performs Well in STEMI Patients

December 17, 2012

News Industry News

CID Spa releases the NEXT Study 24-months data on its Cre8™ DES at TCT 2012

December 10, 2012

News Daily News

Su Publica el PACIFIER: Los Balones liberadores de Fármacos Ayudan a tratar las Lesiones Femoropoplíteas

Caitlin E. Cox

December 09, 2012

News Daily News

PACIFIER Published: Drug-Eluting Balloon Helps Treat Femoropopliteal Lesions

Caitlin E. Cox

December 09, 2012

News Daily News

Registry Study Defines Proper Role for Embolization Device for Intracranial Aneurysm

December 05, 2012

News Daily News

BELLO: Drug-Coated Balloons Take on De Novo Lesions vs. DES

Caitlin E. Cox

November 15, 2012

News Daily News

BELLO: Balones recubiertos de Fármacos contra Lesiones De Novo frente a SLF

Caitlin E. Cox

November 15, 2012

Presentation TCT 2012

First-in-Man Results with a Novel Nanoparticle-Based Sirolimus-Coated Balloon in Coronary In-Stent Restenosis Lesions (Concept Medical)

Presenter: Suhas Lele

October 25, 2012

Presentation TCT 2012

Evaluation and Treatment of In-Stent Restenosis

Presenter: Christoph Kaiser

October 25, 2012

News Industry News

Elixir Medical Announces Enrollment Completion of the DESolve Nx Pivotal Trial for Fully Bioresorbable Coronary Scaffold System

October 25, 2012

Presentation TCT 2012

Case 2: IVUS Guided Diagnosis and Therapy of In-Stent Restenosis

Presenter: Ricardo Costa

October 24, 2012

News Industry News

Second Generation Drug-Eluting Stents are Safe and Effective in Treatment of Left Main Coronary Artery Disease

October 24, 2012

News Conference News TCT 2012

Promising Outlook for Bioabsorbable Scaffolds, Polymers in Next-Generation Stents

October 24, 2012

Presentation TCT 2012

In-Stent Restenosis: Mechanisms, Predictors, and Treatment

Presenter: Roxana Mehran

October 23, 2012

Presentation TCT 2012

What Can Advanced Stent Imaging Tell Us About In-Stent Restenosis, Plaque Prolapse, and Design of Future Stents?

Presenter: Mark Wholey

October 22, 2012

Presentation TCT 2012

Drug-Coated Balloons for SFA In-Stent Restenosis: A Simple Solution for a Tenacious Problem?

Presenter: Eugenio Stabile

October 22, 2012

Advertisement

Un Nuevo Anti Inflamatorio podría Reducir la Estenosis tras la Implantación de SMD en Pacientes de Alto Riesgo

Novel Anti-inflammatory May Reduce Restenosis After BMS in High-Risk Patients

TCTMD’s Top 10 Most Popular News Stories for 2012

ROTAXUS Published: Rotational Atherectomy Does Not Increase DES Efficacy

APPOSITION II Published: Self-Expanding Stent Performs Well in STEMI Patients

CID Spa releases the NEXT Study 24-months data on its Cre8™ DES at TCT 2012

Su Publica el PACIFIER: Los Balones liberadores de Fármacos Ayudan a tratar las Lesiones Femoropoplíteas

PACIFIER Published: Drug-Eluting Balloon Helps Treat Femoropopliteal Lesions

Registry Study Defines Proper Role for Embolization Device for Intracranial Aneurysm

BELLO: Drug-Coated Balloons Take on De Novo Lesions vs. DES

BELLO: Balones recubiertos de Fármacos contra Lesiones De Novo frente a SLF

First-in-Man Results with a Novel Nanoparticle-Based Sirolimus-Coated Balloon in Coronary In-Stent Restenosis Lesions (Concept Medical)

Evaluation and Treatment of In-Stent Restenosis

Elixir Medical Announces Enrollment Completion of the DESolve Nx Pivotal Trial for Fully Bioresorbable Coronary Scaffold System

Case 2: IVUS Guided Diagnosis and Therapy of In-Stent Restenosis

Second Generation Drug-Eluting Stents are Safe and Effective in Treatment of Left Main Coronary Artery Disease

Promising Outlook for Bioabsorbable Scaffolds, Polymers in Next-Generation Stents

In-Stent Restenosis: Mechanisms, Predictors, and Treatment

What Can Advanced Stent Imaging Tell Us About In-Stent Restenosis, Plaque Prolapse, and Design of Future Stents?

Drug-Coated Balloons for SFA In-Stent Restenosis: A Simple Solution for a Tenacious Problem?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content